Cargando…
Excipient-Free Pure Drug Nanoparticles Fabricated by Microfluidic Hydrodynamic Focusing
Nanoprecipitation is one of the most versatile methods to produce pure drug nanoparticles (PDNPs) owing to the ability to optimize the properties of the product. Nevertheless, nanoprecipitation may result in broad particle size distribution, low physical stability, and batch-to-batch variability. Mi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069523/ https://www.ncbi.nlm.nih.gov/pubmed/33920184 http://dx.doi.org/10.3390/pharmaceutics13040529 |
_version_ | 1783683257217318912 |
---|---|
author | Arzi, Roni Sverdlov Kay, Asaf Raychman, Yulia Sosnik, Alejandro |
author_facet | Arzi, Roni Sverdlov Kay, Asaf Raychman, Yulia Sosnik, Alejandro |
author_sort | Arzi, Roni Sverdlov |
collection | PubMed |
description | Nanoprecipitation is one of the most versatile methods to produce pure drug nanoparticles (PDNPs) owing to the ability to optimize the properties of the product. Nevertheless, nanoprecipitation may result in broad particle size distribution, low physical stability, and batch-to-batch variability. Microfluidics has emerged as a powerful tool to produce PDNPs in a simple, reproducible, and cost-effective manner with excellent control over the nanoparticle size. In this work, we designed and fabricated T- and Y-shaped Si-made microfluidic devices and used them to produce PDNPs of three kinase inhibitors of different lipophilicity and water-solubility, namely imatinib, dasatinib and tofacitinib, without the use of colloidal stabilizers. PDNPs display hydrodynamic diameter in the 90–350 nm range as measured by dynamic light scattering and a rounded shape as visualized by high-resolution scanning electron microscopy. Powder X-ray diffraction and differential scanning calorimetry confirmed that this method results in highly amorphous nanoparticles. In addition, we show that the flow rate of solvent, the anti-solvent, and the channel geometry of the device play a key role governing the nanoparticle size. |
format | Online Article Text |
id | pubmed-8069523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80695232021-04-26 Excipient-Free Pure Drug Nanoparticles Fabricated by Microfluidic Hydrodynamic Focusing Arzi, Roni Sverdlov Kay, Asaf Raychman, Yulia Sosnik, Alejandro Pharmaceutics Article Nanoprecipitation is one of the most versatile methods to produce pure drug nanoparticles (PDNPs) owing to the ability to optimize the properties of the product. Nevertheless, nanoprecipitation may result in broad particle size distribution, low physical stability, and batch-to-batch variability. Microfluidics has emerged as a powerful tool to produce PDNPs in a simple, reproducible, and cost-effective manner with excellent control over the nanoparticle size. In this work, we designed and fabricated T- and Y-shaped Si-made microfluidic devices and used them to produce PDNPs of three kinase inhibitors of different lipophilicity and water-solubility, namely imatinib, dasatinib and tofacitinib, without the use of colloidal stabilizers. PDNPs display hydrodynamic diameter in the 90–350 nm range as measured by dynamic light scattering and a rounded shape as visualized by high-resolution scanning electron microscopy. Powder X-ray diffraction and differential scanning calorimetry confirmed that this method results in highly amorphous nanoparticles. In addition, we show that the flow rate of solvent, the anti-solvent, and the channel geometry of the device play a key role governing the nanoparticle size. MDPI 2021-04-10 /pmc/articles/PMC8069523/ /pubmed/33920184 http://dx.doi.org/10.3390/pharmaceutics13040529 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Arzi, Roni Sverdlov Kay, Asaf Raychman, Yulia Sosnik, Alejandro Excipient-Free Pure Drug Nanoparticles Fabricated by Microfluidic Hydrodynamic Focusing |
title | Excipient-Free Pure Drug Nanoparticles Fabricated by Microfluidic Hydrodynamic Focusing |
title_full | Excipient-Free Pure Drug Nanoparticles Fabricated by Microfluidic Hydrodynamic Focusing |
title_fullStr | Excipient-Free Pure Drug Nanoparticles Fabricated by Microfluidic Hydrodynamic Focusing |
title_full_unstemmed | Excipient-Free Pure Drug Nanoparticles Fabricated by Microfluidic Hydrodynamic Focusing |
title_short | Excipient-Free Pure Drug Nanoparticles Fabricated by Microfluidic Hydrodynamic Focusing |
title_sort | excipient-free pure drug nanoparticles fabricated by microfluidic hydrodynamic focusing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069523/ https://www.ncbi.nlm.nih.gov/pubmed/33920184 http://dx.doi.org/10.3390/pharmaceutics13040529 |
work_keys_str_mv | AT arzironisverdlov excipientfreepuredrugnanoparticlesfabricatedbymicrofluidichydrodynamicfocusing AT kayasaf excipientfreepuredrugnanoparticlesfabricatedbymicrofluidichydrodynamicfocusing AT raychmanyulia excipientfreepuredrugnanoparticlesfabricatedbymicrofluidichydrodynamicfocusing AT sosnikalejandro excipientfreepuredrugnanoparticlesfabricatedbymicrofluidichydrodynamicfocusing |